{ "data": { "asOf": "2026-10-30T22:26:12.958Z", "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "byRegistry": { "clinicaltrials_gov": 1 }, "canonicalTrial": { "canonicalId": "NCT07482787", "title": "Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa", "scientificTitle": "A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa", "status": "recruiting", "studyType": "interventional", "phase": [ "PHASE3" ], "conditions": [ "Epidermolysis Bullosa (EB)" ], "interventions": [ { "name": "SD-101 Dermal Cream (6%)", "type": "DRUG", "description": "SD-101 is a white, crystalline powder that is formulated within an odorless, soft, white cream base. SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients." }, { "name": "Vehicle (SD-101 0%)", "type": "DRUG", "description": "A white, crystalline powder that is formulated within an odorless, soft, white cream base. It contains no allantoin, only excipients." } ], "sponsor": { "name": "Paradigm Therapeutics", "type": "INDUSTRY" }, "locations": [ { "city": "Rancho Santa Margarita", "country": "United States", "facility": "Mission Dermatology" }, { "city": "Redwood City", "country": "United States", "facility": "Stanford University School of Medicine Dermatology Department" }, { "city": "Philadelphia", "country": "United States", "facility": "Children's Hospital of Philadelphia" }, { "city": "Charleston", "country": "United States", "facility": "Medical University of South Carolina Department of Dermatology and Dermatologic Surgery" } ], "outcomes": { "other": [], "primary": [ "Target wound closure" ], "secondary": [ "Change in wound burden", "Change in itching" ] }, "eligibility": { "sex": "ALL", "criteria": "Inclusion Criteria:\n\n1. Informed Consent (ICF) form signed by the patient or patient's legal representative. Since all patients with be 12 years old or younger at study entry, signed assent from the patient's legal representative will be required.\n2. Patient (or caretaker) must be willing to comply with all protocol requirements.\n3. Diagnosis of Simplex, Recessive Dystrophic, or JEB-nH (intermediate) EB.\n4. Patient must have 1 target wound (size 10 to 50 cm2).\n5. Patients must be between 28 days to 12 years at study entry\n6. Target wound must be present for 21 days or more.\n7. Patients must have wound burden based on BSA of ≥5% at baseline\n\nExclusion Criteria:\n\n1. Patients who do not meet the entry criteria outlined above.\n2. Selected target wound cannot have clinical evidence of local infection.\n3. Use of any investigational drug or approved EB therapy within 30 days before enrollment.\n4. Use of immunotherapy or cytotoxic chemotherapy within 60 days before enrollment.\n5. Use of systemic or topical steroidal therapy within 30 days before enrollment. (Inhaled steroids and ophthalmic drops containing steroids are allowed)\n6. Use of systemic antibiotics within 7 days before enrollment.\n7. Current or former malignancy.\n8. Participant is one of the following:\n\n 1. Not of childbearing potential (premenarchal or male/not in possession of a uterus).\n 2. If of childbearing potential, is nonpregnant (negative urine pregnancy test results at Screening), nonlactating, and practicing 1 of the following medically acceptable methods of birth control:\n\n * Abstinence from heterosexual intercourse as a lifestyle choice.\n * Hormonal methods such as oral, implantable, injectable, or transdermal contraceptives for a minimum of 1 full cycle (based on the participant's usual menstrual cycle period) before product administration.\n * Intrauterine device. If male, is willing to use a highly effective method of contraception throughout the study period.", "maximumAge": "12 Years", "minimumAge": "28 Days", "healthyVolunteers": false }, "enrollment": { "type": "ESTIMATED", "count": 80 }, "startDate": "2026-07-21", "completionDate": "2027-06-17", "lastUpdated": "2026-10-15T00:00:00.000Z", "firstPosted": "2026-03-19T00:00:00.000Z", "resultsAvailable": false, "sourceRegistries": [ "clinicaltrials_gov" ], "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07482787" ] }, "identifiers": [ { "idType": "nct", "idValue": "NCT07482787", "declaredBy": "clinicaltrials_gov" } ], "sourceRecords": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT07482787", "sourceUrl": "https://clinicaltrials.gov/study/NCT07482787", "sourceStatus": "RECRUITING", "retrievedAt": "2026-10-28T04:33:15.849Z", "payloadSha256": "4b12789aa1299d3291452f4d7b509aa838b1b4a7833d8557dc626e5bd711c064", "piiRedacted": true } ], "citation": { "canonicalId": "NCT07482787", "sources": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT07482787", "verifyAt": "https://clinicaltrials.gov/study/NCT07482787", "retrievedAt": "2026-10-28T04:33:15.849Z", "payloadSha256": "4b12789aa1299d3291452f4d7b509aa838b1b4a7833d8557dc626e5bd711c064", "text": "ClinicalTrials.gov, record NCT07482787 (https://clinicaltrials.gov/study/NCT07482787), retrieved 2026-10-28, licence: public-domain." } ], "crossRegistry": false, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "text": "Trial NCT07482787, registered in ClinicalTrials.gov, retrieved 2026-10-28. Verify at the source URLs listed; each retrieval is checksummed.", "note": "Only one registry is known to hold this trial. Absence from the others is not evidence it was not registered there." }, "provenanceNote": "Personal contact fields (names, emails, phone numbers, addresses) are stripped from every stored payload. No participant-level data is collected or served." }, "_meta": { "api": "The Last Economy Wire: World Trials API", "version": "1.0", "schemaVersion": "1", "correlationId": "req_rGXjsiAjYNTp", "generatedAt": "2026-10-30T22:26:12.958Z", "documentation": "https://negativeresistance.com/embed", "license": "Free for any use. Attribution appreciated.", "degraded": false, "provenance": { "sources": [ "clinicaltrials_gov" ], "attribution": { "clinicaltrials_gov": "ClinicalTrials.gov: licence: public-domain, https://clinicaltrials.gov/data-api/api-docs" }, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "limitations": [], "provenanceEndpoint": "/api/v1/sources" }, "freshness": { "newestEvidenceAt": null, "lastSyncedAt": { "clinicaltrials_gov": "2026-10-28T04:33:30.663Z" }, "degradedSources": [], "worldwide": false, "maxAgeHours": 65.9, "fromCache": false }, "links": { "discovery": "https://negativeresistance.com/api/v1", "openapi": "https://negativeresistance.com/api/v1/openapi.json", "mcp": "https://negativeresistance.com/api/v1/mcp", "agentCard": "https://negativeresistance.com/.well-known/agent.json", "aiPlugin": "https://negativeresistance.com/.well-known/ai-plugin.json", "sdk": "https://negativeresistance.com/api/v1/sdk", "status": "https://negativeresistance.com/api/v1/status", "provenance": "https://negativeresistance.com/api/v1/sources", "contract": "https://negativeresistance.com/api/v1/contract", "curriculum": "https://negativeresistance.com/api/v1/curriculum", "graph": "https://negativeresistance.com/api/v1/graph", "openQuestions": "https://negativeresistance.com/api/v1/open-questions", "scoreboard": "https://negativeresistance.com/api/v1/scoreboard", "findings": "https://negativeresistance.com/api/v1/findings", "claims": "https://negativeresistance.com/api/v1/claims", "threads": "https://negativeresistance.com/api/v1/threads", "assignment": "https://negativeresistance.com/api/v1/assignment", "changes": "https://negativeresistance.com/api/v1/changes", "hello": "https://negativeresistance.com/api/v1/hello", "errors": "https://negativeresistance.com/api/v1/errors", "webhooks": "https://negativeresistance.com/api/v1/webhooks", "a2a": "https://negativeresistance.com/api/v1/a2a", "deadEnds": "https://negativeresistance.com/api/v1/dead-ends", "decompositions": "https://negativeresistance.com/api/v1/decompositions", "rungs": "https://negativeresistance.com/api/v1/rungs", "methods": "https://negativeresistance.com/api/v1/methods", "reality": "https://negativeresistance.com/api/v1/reality", "council": "https://negativeresistance.com/api/v1/council", "calibration": "https://negativeresistance.com/api/v1/calibration", "freshness": "https://negativeresistance.com/api/v1/freshness", "mission": "https://negativeresistance.com/api/v1/mission", "twin": "https://negativeresistance.com/api/v1/twin", "twinExperiment": "https://negativeresistance.com/api/v1/twin/experiment", "betaCell": "https://negativeresistance.com/api/v1/twin/beta-cell", "patientModel": "https://negativeresistance.com/api/v1/twin/patient-model", "agentCardCanonical": "https://negativeresistance.com/.well-known/agent-card.json", "collaborate": "https://negativeresistance.com/collaborate", "manifesto": "https://negativeresistance.com/about", "documentation": "https://negativeresistance.com/embed", "connect": "https://negativeresistance.com/connect", "llmsTxt": "https://negativeresistance.com/llms.txt", "llmsFullTxt": "https://negativeresistance.com/llms-full.txt" }, "disclaimer": "Research data from public registries and literature; not medical advice." } }